Aperio Group’s Prothena Corp PRTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$400K Sell
33,293
-1,329
-4% -$15.7K ﹤0.01% 2065
2020
Q3
$346K Buy
34,622
+6,565
+23% +$79K ﹤0.01% 2007
2020
Q2
$293K Buy
28,057
+921
+3% +$10.2K ﹤0.01% 2037
2020
Q1
$290K Buy
27,136
+8,129
+43% +$98.5K ﹤0.01% 1923
2019
Q4
$301K Buy
19,007
+3,423
+22% +$36.7K ﹤0.01% 2058
2019
Q3
$122K Buy
15,584
+6,157
+65% +$54.7K ﹤0.01% 2227
2019
Q2
$100K Sell
9,427
-1,629
-15% -$16.7K ﹤0.01% 2387
2019
Q1
$134K Buy
+11,056
New +$138K ﹤0.01% 2216
2018
Q2
Sell
-6,054
Closed -$222K 2279
2018
Q1
$222K Buy
+6,054
New +$220K ﹤0.01% 2095
2017
Q4
Sell
-5,858
Closed -$379K 2254
2017
Q3
$379K Buy
5,858
+815
+16% +$49.9K ﹤0.01% 1805
2017
Q2
$273K Buy
5,043
+687
+16% +$36.6K ﹤0.01% 1942
2017
Q1
$243K Buy
+4,356
New +$229K ﹤0.01% 1940
2016
Q4
Sell
-3,501
Closed -$210K 2134
2016
Q3
$210K Buy
+3,501
New +$188K ﹤0.01% 1913

Other funds holding PRTA

Aperio Group's PRTA Position: Q4 2020 in Review

Aperio Group reduced its Prothena Corp (PRTA) stake by 3.8% in Q4 2020, selling an estimated $15.7K and leaving 33,293 shares worth $400K. The position accounts for ﹤0.01% of the portfolio, ranked #2065.

Aperio Group first reported a position in PRTA in Q3 2016 and has held it in 13 quarters since. 140 funds tracked by Wall St. Rank hold PRTA as of Q4 2020.

  • Aperio Group held 33,293 shares of Prothena Corp worth $400K as of Q4 2020.
  • Aperio Group sold 1,329 Prothena Corp shares in Q4 2020, an estimated $15.7K.
  • Prothena Corp made up ﹤0.01% of Aperio Group's portfolio in Q4 2020, its #2065 holding.
  • Aperio Group first reported a position in Prothena Corp in Q3 2016 and has held it in 13 quarters since.
  • 140 funds tracked by Wall St. Rank held Prothena Corp as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.